Cargando…
Prostaglandin E(2 )receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein
BACKGROUND: The pathogenesis of idiopathic Parkinson's disease (PD) remains elusive, although evidence has suggested that neuroinflammation characterized by activation of resident microglia in the brain may contribute significantly to neurodegeneration in PD. It has been demonstrated that aggre...
Autores principales: | Jin, Jinghua, Shie, Feng-Shiun, Liu, Jun, Wang, Yan, Davis, Jeanne, Schantz, Aimee M, Montine, Kathleen S, Montine, Thomas J, Zhang, Jing |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766347/ https://www.ncbi.nlm.nih.gov/pubmed/17204153 http://dx.doi.org/10.1186/1742-2094-4-2 |
Ejemplares similares
-
The Effects of Co-Treatment of 9-cis-Retinoic Acid and 15-Deoxy-Δ (12,14)-prostaglandin J2 on Microglial Activation
por: Hsu, Pei-Chien, et al.
Publicado: (2011) -
Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immune response in vivo
por: Milatovic, Dejan, et al.
Publicado: (2004) -
Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor
por: Carlson, Noel G, et al.
Publicado: (2009) -
Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration
por: Davis, Marie Y., et al.
Publicado: (2016) -
Non-cell-autonomous Neurotoxicity of α-synuclein Through Microglial Toll-like Receptor 2
por: Kim, Changyoun, et al.
Publicado: (2016)